US OptionsDetailed Quotes

CPRX240719P15000

Watchlist

0.05
0.000.00%

15min DelayTrading Jul 18 15:02 ET

0.00High0.00Low

Catalyst Pharmaceuticals Stock Discussion

Meltyy

May 24 03:20

See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb(BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals(REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US)$ : Augtyro...

Trytosaveabit

May 8 15:21

Solid

$Catalyst Pharmaceuticals(CPRX.US)$ May 08 (Reuters) - Catalyst Pharmaceuticals Q1 Net Income USD 23.3 Million.
Q1 Adjusted Net Income USD 46.8 Million Vs. Ibes Estimate USD 23.7 Million
Q1 Operating Income USD 27.1 Million Vs. Ibes Estimate USD 25.1 Million
Outlook FY Revenue USD 455-475 Million

Moomoo AI

Mar 22 09:45

The absence of insider buying at Catalyst Pharmaceuticals over the past year is concerning. However, the high level of insider ownership indicates alignment with shareholder interests. Insider selling, even below the current price, raises questions about their view on the company's valuation.

Possible Bearish Signals With Catalyst Pharmaceuticals Insiders Disposing Stock

MARKET-TEST-DUMMY

Jan 28 18:24

hello?

$Catalyst Pharmaceuticals(CPRX.US)$ are you looking at me?

Moomoo AI

Jan 4 11:22

Investors are ostensibly keeping Catalyst Pharmaceuticals' P/E high due to expectations of its future growth surpassing the market. Currently, shareholders are confident in future earnings and do not foresee a significant dip in the share price in the near future.

Why Investors Shouldn't Be Surprised By Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) P/E

Moomoo AI

Dec 13, 2023 04:58

While the level of insider ownership is robust, it is not outstanding. The recent insider selling without any corresponding insider buying over the past three months or the past year signals caution towards the company's stock.

Have Catalyst Pharmaceuticals Insiders Been Selling Stock?

Moomoo AI

Dec 4, 2023 07:06

The CEO of Catalyst Pharmaceuticals expressed optimism about the appointment of Michael W. Kalb as new CFO and the promotions, which are expected to drive transformative contributions to the company's short and long-term growth.

Press Release: Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

Moomoo AI

Dec 3, 2023 07:47

The previous sell-offs may present an opportunity to invest in Catalyst Pharmaceuticals given the long-term profit trajectory evident from their five-year performance. Nonetheless, investors are advised to consider the potential warning signs and other influential market conditions before making decisions.

Catalyst Pharmaceuticals (NASDAQ:CPRX) Increases 5.4% This Week, Taking Five-year Gains to 520%

72765352

Oct 29, 2023 07:43

APLM Warrants price target of 11.50 found in 424B3 filing

$Apollomics(APLM.US)$
$Prestige Wealth(PWM.US)$ $Guardforce AI(GFAI.US)$ $Intuitive Machines(LUNR.US)$ $Amesite(AMST.US)$ $Tenax Therapeutics(TENX.US)$ $Buzzfeed(BZFD.US)$ $COMSovereign(COMS.US)$ $Minerva Surgical(UTRS.US)$ $Ault Alliance(AULT.US)$ $AMTD Digital(HKD.US)$ $Micromobility.com(MCOM.US)$ $Cadrenal Therapeutics(CVKD.US)$ $Genius Group(GNS.US)$ $BBBYQ$ $Cosmos Health(COSM.US)$ $Panbela Therapeutics(PBLA.US)$ $APGN$ $Annexon(ANNX.US)$ $Golden Sun Health Technology(GSUN.US)$ $Laser Photonics(LASE.US)$ $Cemtrex(CETX.US)$ $Troika Media(TRKA.US)$ $NextPlay Technologies(NXTP.US)$ $China Pharma(CPHI.US)$ $Dianthus Therapeutics(DNTH.US)$ $Nuwellis(NUWE.US)$ $OpGen(OPGN.US)$ $Powerbridge Technologies(PBTS.US)$ $Healthcare Triangle(HCTI.US)$ $Digital Brands Group(DBGI.US)$ $Kintara Therapeutics(KTRA.US)$ $Ensysce Biosciences(ENSC.US)$ $Houston American Energy(HUSA.US)$ $AlTi Global(ALTI.US)$ $Zovio(ZVOI.US)$ $Agrify(AGFY.US)$ $Oblong(OBLG.US)$ $SOBR Safe(SOBR.US)$ $Nauticus Robotics(KITT.US)$ $Avenue Therapeutics(ATXI.US)$ $Blue Apron(APRN.US)$ $Bright Minds Biosciences Inc(DRUG.CA)$ $Applied DNA Sciences(APDN.US)$ $Magic Empire Global(MEGL.US)$ $Evolve Transition Infrastructure(SNMP.US)$ $Vivos Therapeutics(VVOS.US)$ $American Strategic Investment(NYC.US)$ $Icecure Medical(ICCM.US)$ $Applied Uv(AUVI.US)$ $ShiftPixy(PIXY.US)$ $Tempest Therapeutics(TPST.US)$ $Tupperware Brands(TUP.US)$ $Applied Uv(AUVI.US)$ $Yield10 Bioscience(YTEN.US)$ $Assure(IONM.US)$ $Versus Systems(VS.US)$ $The Alkaline Water(WTER.US)$ $TC BioPharm(TCBP.US)$ $Unicycive Therapeutics(UNCY.US)$ $Peraso(PRSO.US)$ $PARTS iD(ID.US)$ $FTSE Singapore Straits Time Index(.STI.SG)$ $Ascent Solar Technologies(ASTI.US)$ $Abri SPAC I(ASPA.US)$ $Connexa Sports Technologies(CNXA.US)$ $Unique Fabricating(UFAB.US)$ $Aditxt(ADTX.US)$ $PainReform(PRFX.US)$ $Alpha Technology(ATGL.US)$ $Urgent.ly(ULY.US)$ $Bruush Oral Care(BRSH.US)$ $ReShape Lifesciences(RSLS.US)$ $Appreciate Holdings(SFR.US)$ ...

Trytosaveabit

Oct 26, 2023 15:17

LMAO!

$Catalyst Pharmaceuticals(CPRX.US)$ Amazing! a company gets a 3rd party to say its phase 2 data looks great, and that ticker explodes 300%? Then you have this and like $Ardelyx(ARDX.US)$ that get actual FDA approval and it dont move! hehehe so crazy! i mean i still think this does go? its just a matter of when?

No comment yet